Outcomes of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Followed by High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDCT/ASCT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

被引：0
|
作者：
Abdallah, Al-Ola [1 ]
Mohyuddin, Ghulam Rehman [1 ]
Mahmoudjafari, Zahra [2 ]
Shebli, Atrash [3 ]
Kawsar, Hameem [2 ]
Sigle, Monia [2 ]
Shune, Leyla [1 ]
McGuirk, Joseph [1 ]
Ganguly, Siddhartha [1 ]
机构：
[1] Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA
[2] Univ Kansas, Med Ctr, Westwood, KS USA
[3] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
daratumumab; pomalidomide; relapsed/refractory myeloma; MM;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-235
引用
收藏
页码：S303 / S303
页数：1
相关论文
共 50 条
  • [1] Outcomes of daratumumab, pomalidomide, and dexamethasone (DPd) followed by high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) in patients with relapsed/refractory myeloma RRMM.
    Abdallah, Al-Ola A.
    Dias, Ajoy
    Kawsar, Hameem, I
    Mohyuddin, Ghulam Rehman
    Sigle, Monia
    Mahmoudjafari, Zahra
    Shune, Leyla Osman
    McGuirk, Joseph
    Ganguly, Siddhartha
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Outcomes of Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Who Responded to Daratumumab, Pomalidomide and Dexamethasone (DPd), Followed By High Dose Chemotherapy/Autologous Stem Cell Transplantation (HDCT/ASCT) Versus (DPd) AloneEE
    Jain, Jayanshu
    Khasawneh, Ghena
    Hashmi, Hamza
    Mohan, Meera
    Mahmoudjafari, Zahra
    Cui, Wei
    McGuirk, Joseph P.
    Shune, Leyla O.
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Atrash, Shebli
    BLOOD, 2022, 140 : 10587 - 10588
  • [3] Outcomes of Daratumumab, Pomalidomide, and Dexamethasone, Followed by High-dose Chemotherapy and Autologous Stem Cell Transplantation, in Patients With Relapsed/Refractory Multiple Myeloma
    Abdallah, Al-Ola
    Mohyuddin, Ghulam Rehman
    Mahmoudjafari, Zahra
    Atrash, Shebli
    Kawsar, Hameem
    Sigle, Monia
    Shune, Leyla
    McGuirk, Joseph
    Ganguly, Siddhartha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (02): : E212 - E219
  • [4] Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation
    Abdallah, Al-Ola
    Dunavin, Neil
    McClune, Brian
    Shune, Leyla
    Dias, Ajoy L.
    Mahmoudjafari, Zahra
    Hochard, Erica
    McGuirk, Joseph P.
    Ganguly, Siddhartha
    BLOOD, 2018, 132
  • [5] Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple Myeloma
    Hashmi, Hamza
    Atrash, Shebli
    Jain, Jayanshu
    Khasawneh, Ghena
    Mohan, Meera
    Mahmoudjafari, Zahra
    Cui, Wei
    McGuirk, Joseph
    Shune, Leyla
    Ahmed, Nausheen
    Abdallah, Al-Ola
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (04): : 262e1 - 262e6
  • [6] Daratumumab with Pomalidomide and Dexamethasone at First Relapse in Relapsed and/or Refractory Multiple Myeloma ( RRMM) Patients
    不详
    BLOOD, 2021, 138
  • [7] Daratumumab Combined with Pomalidomide and Dexamethasone (DPd) for Patients with Relapsed/Refractory Multiple Myeloma in a Single Institution
    Abdallah, Al-Ola
    McGuirk, Joseph P.
    Shune, Leyla
    Dunavin, Neil
    Mahmoudjafari, Zahra
    Hochard, Erica
    Ganguly, Siddhartha
    BLOOD, 2017, 130
  • [8] High dose chemotherapy (HDCT) followed by autologous stem cell transplantation (ASCT) in multiple myeloma (MM): An analysis of prognostic factors.
    Lalit, K
    Ganessan, K
    Wadhwa, J
    Sharma, A
    Kochupillai, V
    BLOOD, 2002, 100 (11) : 474B - 474B
  • [9] Hematological and Non-Hematological Toxicities in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Who Responded to Daratumumab, Pomalidomide, and Dexamethasone (DPd)
    Bellman, Polina
    Cui, Wei
    Mahmoudjafari, Zahra
    Atrash, Shebli
    Paul, Barry
    Hashmi, Hamza
    Banderudrappagari, Rajesh
    Shune, Leyla O.
    Abdallah, Al-Ola
    Ahmed, Nausheen
    BLOOD, 2022, 140 : 8074 - 8075
  • [10] High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
    Rancea, Michaela
    Monsef, Ina
    von Tresckow, Bastian
    Engert, Andreas
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
12345